We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sthree Plc | LSE:STEM | London | Ordinary Share | GB00B0KM9T71 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 429.50 | 430.00 | 447.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Employment Agencies | 1.66B | 56.05M | 0.4156 | 10.33 | 579.28M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/11/2008 08:57 | This company is now safe! Can't say that about many companies in the current climate! | hyper al | |
20/11/2008 08:21 | The lack of reaction to this news just shows how seriously bad the markets are! | hyper al | |
20/11/2008 07:46 | johnjackson5225 You said "FWIW I won't be touching these with a sterilised bargepole" well Pfizer Limited have done what you would not "Stem Cell Sciences plc (AIM:STEM, ASX:STC), a company focused on the commercialisation of stem cells and stem cell technologies, has signed a Master Service Agreement of up to five years with Pfizer Limited, the UK operating unit of the global research-based pharmaceutical company Pfizer, Inc. (NYSE: PFE). Under the terms of the agreement, SCS will provide research services, cell lines, media and reagents to support Pfizer's R&D efforts in this important field." | hyper al | |
23/9/2008 09:42 | Hyper Al I'm sorry (genuinely) to hear about your pension debacle. I do wonder why anyone would bet 70% of a critical asset on a high-risk, high volatility stock though? FWIW I won't be touching these with a sterilised bargepole. JJ | johnjackson5225 | |
28/8/2008 07:47 | Why did they move from Edinburgh? Would it have not been cheaper to have consolidated in Edinburgh? | hyper al | |
22/6/2008 19:25 | some interesting new Stem Cell stuff (the 'science' as opposed to the company): Researchers in the United States have discovered a new group of stem cells that can give rise to heart muscle cells, known as cardiomyocytes, according to a study published Sunday. | don muang | |
20/6/2008 08:08 | 'funny' you should mention the thread .... now after Aus close it's being quoted at 0.35/0.6 there !!! | don muang | |
20/6/2008 07:47 | This reminds me of a mining stock I have traded a few times. THR trades mainly on the Oz market, with very thin volumes in the UK, for me this has caused problem selling the share in any quantity, unless you are trading on the rise. Long term, I like this share, but for general trading it's not ideal and the MM's don't encourage it with such a large spread. | hyper al | |
20/6/2008 06:44 | .... and to answer my own question .... the answer (to what price change in Aus will be in todays session) is down 6%.... | don muang | |
19/6/2008 21:06 | up 18.6% in last Aus session (hence mark-up today here) ..... await with interest to see what happens in coming Aus session... >Hyper Al - 13 Jun'08 >I do wish you luck with your investment Thanks >in the current climate share holders will want to see profits in quite short time scales. Disagree with that. In current climate then investors (as opposed to traders) are happy to accumulate some undersold situations and sit on them awaiting developements .... | don muang | |
13/6/2008 18:15 | Don Muang I lost about 70% of my pension on PRM. I transferred my pension into a SIPP for the purpose of investing in PRM, my main purchase was around £1.90 and no the peak was not 150 but 218, I should know, as I and my friends were buying at those levels. We all lost a fortune! I like the quality of the science coming out of STEM, but there is no way I am going to invest in such a company, until it can break even or make a profit. I learnt a lot through my PRM loss. I took a gamble and loss. Not again. Business is about making money, not just doing research, in the current climate share holders will want to see profits in quite short time scales. IMHO. I do wish you luck with your investment, like I say I like this company, so I hope they and you do well. | hyper al | |
06/6/2008 00:12 | .... but wasn't it during dot com era that PRM was first 'noticed' ..... at one point during 1999 you could pick it up for around 8p ..... then it peaked at around 150 in early 2000..... I'm not buying anymore STEM..... I've accumulated enough already ..... now happy to sit on it and wait ..... only time will tell if that is a good or bad decision..... | don muang | |
05/6/2008 23:41 | Don Muang PRM was not quite a dot com, most of it's gains were made due to it's research into proteins relating to CJD and the hope that they could create a suitable test. The only trouble is they did not make any money, their best chance was a test for stroke, but that all went wrong (not all PRM's fault) PRM have some great patents and do excellent research, but I don't believe it's covering it's operating costs, although I have not looked for a while. As for this one, when they announce a large milestone payment, the share price may turn. I'm certainly watching and I hope you don't get me wrong, this company is doing an excellent job and they deserve praise for that, but I'm in shares as an investment, not for charity (if I had enough money, I would be). How bit is the market for Stems products? How much is the market worth? | hyper al | |
05/6/2008 20:39 | Another day, another patent for STEM and it's still 'under the radar'..... time will tell if it all comes good ... Hyper .... I'm old enough to remember when PRM was 'under the radar' and the share price was in single figures..... then it fairly quickly became a 'ten-bagger' during dot-com boom..... | don muang | |
04/6/2008 21:02 | Don Muang I'm watching this company. It has enormous potential, but it needs to become more commercial. I lost lots of money on PRM, they were the same, not commercial enough. | hyper al | |
04/6/2008 19:07 | Another piece of news today: 'Stem Cell Sciences Plc. said the European patent office has granted it a second patent for "Nanog", a key protein factor used to convert adult cells back into a pluripotent state.' | don muang | |
22/5/2008 08:22 | ... looks like April might have been the low point for this ..... starting to climb back up on various news.... let's see if the climb turns out to be exponential..... | don muang | |
22/5/2008 08:18 | Stem Cell Sciences plc (AIM:STEM, ASX:STC) today announced the launch of Culticell iSTEM, a novel, serum-free, feeder-free embryonic stem (ES) cell research media product, that maintains cells in their basal, pluripotent state. Culticell iSTEM provides researchers with a purer starting point for investigating the biological potential of ES cells. "Professor Smith's research is a major step forward in embryonic stem cell research and elucidates some of the early mechanisms involved in self-renewal and differentiation," noted Dr Tim Allsopp, Chief Scientific Officer of Stem Cell Sciences. "We have now leveraged this significant advance into our novel media product Culticell iSTEM, which we believe will help provide researchers with a more pure starting point for embryonic stem cell research." Interesting stuff ! | abally99 | |
20/5/2008 22:13 | Nope, but those with stem cell IP (whoever they are) will start seeing more action IMO | the_doctor | |
20/5/2008 22:12 | Anyone in these? | hyper al | |
26/3/2008 13:29 | not actually a doctor but that said, probably more qualified than a Dr to look into the health of this company. not a lot of time these days, but will post my findings if I get around to looking into it. The UK MPs wont stop the work SCS does... and if that work produces the desired results, they will have to change their views. ie. looks like sentiment is unfairly hitting this | the_doctor | |
25/3/2008 19:23 | Might take a look into this. If cash levels are ok and they have decent proprietary tech, it could be a worthwhile punt on bid prospects?? | the_doctor |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions